Lupin Pharma ties up with US firm

By siliconindia staff writer   |   Thursday, 27 January 2005, 08:00 Hrs
Printer Print Email Email
MUMBAI:Pharma major Lupin Ltd has tied up with Cornerstone BioPharma Inc.of US for marketing its anti-infective brand Cefixime Suprax.

Cornerstone's sales force will co-promote Suprax with a focus on primary care physicians, who were not covered by the company, the company said.

Suprax, developed by the Mumbai based Lupin, was approved in 2004 and has been promoted by Lupin Pharma Inc's pediatric focused sales force.

Lupin said the partnership represents a significant expansion in the scope of physician coverage for Suprax in the $1.2 billion oral suspension anti-infective market.



SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..